OneMedNet Corporation's President and CEO, Aaron Green, issued a letter to shareholders highlighting significant strategic progress over the past year. Key achievements include onboarding five major data marketplaces and surpassing 121 million clinical exams in its network.
The company is actively developing an AI-driven toolset to anonymize and de-identify data across multiple industries. This technological advancement aims to capitalize on the growing demand for de-identified, regulatory-grade Real-World Data.
OneMedNet has introduced a subscription-based Data License Agreement (DLA) structure to drive Annual Recurring Revenue (ARR). This model supports near real-time data updates and incentivizes network expansion by sharing revenue with partner hospitals and clinics.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.